Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell cycle studies in acute myelogenous leukemia.

H D Preisler, A Raza

    Leukemia
    |August 1, 1992
    PubMed
    Summary

    Altering leukemia cell proliferation may improve therapy response. Appropriate methods are needed to evaluate bioactive agents

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Transient Large-Scale Anisotropy in TeV Cosmic Rays due to an Interplanetary Coronal Mass Ejection.

    Physical review letters·2026
    Same author

    First Detection of Ultrahigh Energy Emission from Gamma-Ray Binary LS I +61° 303.

    Physical review letters·2026
    Same author

    Evidence of Cosmic-Ray Acceleration up to Sub-PeV Energies in the Supernova Remnant IC 443.

    Physical review letters·2026
    Same author

    Precise Measurement of the Cosmic Ray Helium Spectrum above 0.1 PeV.

    Physical review letters·2026
    Same author

    A REVIEW OF CURRENT CONCEPTS IN THE MANAGEMENT OF BONE DEFECTS IN TRAUMA AND ORTHOPAEDICS.

    Georgian medical news·2025
    Same author

    All-Sky Search for Individual Primordial Black Hole Bursts with LHAASO.

    Physical review letters·2025

    Area of Science:

    • * Hematology and Oncology
    • * Molecular Biology
    • * Pharmacology

    Background:

    • * Leukemia cell proliferation significantly influences therapeutic outcomes.
    • * Modulating these proliferative characteristics presents a potential therapeutic strategy.
    • * Evaluating the in vivo effects of bioactive agents on leukemia cells is crucial.

    Discussion:

    • * The study emphasizes the need for robust methodologies to assess therapeutic interventions.
    • * Investigating the impact of bioactive agents on leukemia cell kinetics is essential.
    • * Translating preclinical findings to clinical settings requires careful evaluation.

    Key Insights:

    • * Leukemia cell proliferative capacity is a key determinant of treatment efficacy.
    • * Targeting leukemia cell proliferation offers a promising avenue for novel therapies.
    • * In vivo patient studies are critical for validating therapeutic strategies.

    Outlook:

    • * Development of advanced methods for evaluating drug efficacy in leukemia patients.
    • * Further research into bioactive agents targeting leukemia cell proliferation.
    • * Personalized medicine approaches based on individual leukemia cell characteristics.

    Related Experiment Videos